Cite

HARVARD Citation

    Ali, R. et al. (2016). Genetically modified human CD4+ T cells can be evaluated in vivo without lethal graft‐versus‐host disease. Immunology. 148 (4), pp. 339-351. [Online]. 
  
Back to record